Virtual or hybrid provision of medication abortion (MA), which is also called no-touch or low-touch medication abortion, is one where some or all of the appointments […]

Due to rapid return to fertility following medication abortion (MA), patients should be advised to have a method for contraception at the earlier visits[6]. Patients […]

Ongoing pregnancy[6]: Ongoing pregnancy after medication abortion is uncommon and can be treated with another dose of MISO or with procedural abortion. Procedural abortion is […]

Completion of medication abortion (MA) must be assessed by the provider. Depending on the circumstances, this can be done by obtaining a clinical history, ultrasonography, […]

A follow-up appointment is required to confirm the termination of the pregnancy, manage complications, counsel on contraceptive plans and, if applicable, provide emotional support. Mode […]

Guidelines on Rh screening have been updated. According to the SOGC’s Guideline on Prevention of RhD Alloimmunization published in 2024, for non-sensitized Rh D-negative individuals […]

Patients who have a pregnancy of unknown location (PUL) and request medication abortion (MA) should receive abortion care without delay, provided that they have no […]

Ectopic pregnancy (EP) is rare. It occurs in 1 or 2 out of 100 pregnancies in the general population, and the rate is consistently lower […]

A positive urine beta human chorionic gonadotropin test (βhCG) is sufficiently sensitive to confirm a pregnancy[6]. Ultrasound: Ultrasound provides the most accurate measurement of gestational age […]